Clinical Trial: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

Brief Summary: Neuroendocrine cancer is an unusual disease and often goes undetected by routine imaging. The 68Ga-DOTATATE PET Scan is a novel scanning method that may have improved sensitivity and resolution specifically for neuroendocrine tumors. Patients with neuroendocrine tumors will be imaged with this agent and it will be compared to conventional imaging methods to determine the safety and efficacy of this radiopharmaceutical.